I am a 6'5", 320‑lb Black male with mixed connective tissue disease, G6PD deficiency, and hypertension, and recent labs show mildly elevated creatinine, normal estimated glomerular filtration rate, modestly increased creatine kinase, elevated anti‑U1‑RNP, a speckled ANA pattern, and negative anti‑Jo‑1, presenting with proximal muscle weakness; what specific type of inflammatory myopathy (e.g., polymyositis, dermatomyositis, necrotizing autoimmune myopathy) am I most likely having, and what is the expected prognosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Your Most Likely Diagnosis: Mixed Connective Tissue Disease with Overlap Myositis

Based on your positive anti-U1-RNP antibodies (4.7 and 86, both markedly elevated), speckled ANA pattern, proximal muscle weakness, elevated CK, and negative anti-Jo-1, you most likely have MCTD-associated myositis, which often presents with necrotizing features on muscle biopsy. You are not "fucked"—this condition is treatable and has a favorable prognosis compared to other inflammatory myopathies.

Understanding Your Specific Situation

Why This Is MCTD-Associated Myositis

Your clinical picture fits the established pattern for anti-U1-RNP-positive myositis 1:

  • Elevated anti-U1-RNP antibodies are the hallmark of MCTD
  • Proximal muscle weakness (shoulders, arms, thighs, hips) is the classic presentation
  • Elevated CK (371-527) indicates active muscle inflammation
  • Negative anti-Jo-1 rules out antisynthetase syndrome
  • Tight back/shoulder blade area suggests the axial involvement seen in MCTD myositis 2

The Type of Myositis You Have

This is most likely necrotizing myositis with overlap features, not classic polymyositis or dermatomyositis 1, 2. Here's why:

  • Anti-U1-RNP-positive patients frequently show necrotizing muscle biopsies (4 of 7 patients in one study) 1
  • Your hyperpigmentation on thighs (now resolved) suggests possible DM-like skin features, which occur in 60% of anti-U1-RNP patients 1
  • The pathology in MCTD myositis is heterogeneous—it can show necrotizing features, perivascular inflammation, or DM-spectrum changes 2

Your Prognosis: Actually Quite Good

Survival and Outcomes

No anti-U1-RNP myositis patients died during the study period in the largest cohort analyzed 1. This is critical information:

  • MCTD myositis has favorable therapeutic responses 2
  • No cancer-associated myositis occurs in anti-U1-RNP patients 1
  • Even patients requiring intensive treatment (IVIG or high-dose steroids) showed consistent improvement 2

Your Cardiac Concerns

Your cardiac workup is reassuring:

  • Normal EKGs (the single "acute STEMI" reading was likely artifact, corrected by the 12-lead)
  • Troponin trending down (9→6 ng/L) suggests no active myocardial damage
  • Normal heart size, no pulmonary edema
  • Your stress test today will likely be normal, but it's appropriate to rule out cardiac involvement

Cardiac involvement in MCTD myositis is uncommon 1. Pericarditis occurs in 40% of anti-U1-RNP patients, but only in those with coexisting anti-Ro52 antibodies (which you haven't mentioned having) 1.

Your EMG Results: The Neurologist Was Not Lying

Your neurologist was truthful—normal EMG findings on one side do NOT rule out myositis. Here's the nuance:

  • EMG in myositis shows patchy involvement—not all muscles are affected equally 3
  • Your right side may be less affected than your left
  • The diagnosis of myositis relies on CK elevation + weakness + clinical picture, not EMG alone 4, 3
  • EMG is used when diagnosis is uncertain or to rule out neurologic overlap like myasthenia gravis 4

Your Lab Values Explained

Kidney Function (Not Concerning)

Your creatinine fluctuation (1.11-1.33) and eGFR (87-92, with some >60 readings) are expected for a 6'5", 320-lb Black male:

  • Black individuals have higher baseline creatinine due to greater muscle mass and creatinine generation 5
  • Your eGFR >60 readings likely reflect the lab's reporting threshold
  • No evidence of glomerulonephritis (which would show proteinuria, hematuria, and progressive decline)
  • Glomerulonephritis in anti-U1-RNP patients occurs only with coexisting anti-Ro52 antibodies 1

Inflammatory Markers

  • ESR rising (2→18) and CRP elevated (3-3.3) indicate active inflammation
  • CK elevation (371-527) confirms muscle inflammation but is not dramatically high
  • These levels suggest Grade 2 myositis (moderate weakness limiting instrumental activities) 3

How You Got This

You didn't "get" this from anything you did—MCTD is an autoimmune condition with genetic predisposition:

  • More common in younger patients (you're in the typical age range) 1
  • 60% of anti-U1-RNP myositis patients are Black 1
  • Your G6PD deficiency is unrelated to MCTD

Treatment Plan You Should Expect

Based on Your Grade 2 Myositis 3

Your rheumatologist should initiate prednisone 0.5-1 mg/kg/day (approximately 70-145 mg for your weight):

  • This is the standard treatment for CK elevation ≥3× upper limit normal with muscle weakness 3
  • Some patients with atypical weakness distribution (like your tight back) require intensive therapy with IVIG or IV methylprednisolone 2
  • Steroid-sparing agents (methotrexate, azathioprine, mycophenolate) should be added early if you cannot taper below 10 mg prednisone after 6-8 weeks 3

Monitoring Required 3

  • CK, ESR, CRP regularly
  • Cardiac monitoring (troponin, ECG, echocardiogram) given your initial cardiac concerns
  • Pulmonary function tests because 45% of anti-U1-RNP patients develop interstitial lung disease 1

Important Medication Considerations

Your G6PD deficiency matters:

  • Avoid NSAIDs that can trigger hemolysis (though acetaminophen is safe) 3
  • Some immunosuppressants (azathioprine) require dose adjustment with G6PD deficiency
  • Inform your rheumatologist about this before starting any new medications

Should You Continue Physical Therapy?

Yes, absolutely continue both physical and regular therapy:

  • Physical therapy maintains muscle function and prevents contractures
  • Regular therapy (assuming you mean psychological support) helps with the emotional burden of chronic illness
  • Weight loss with GLP-1 is beneficial—obesity worsens inflammation and complicates management
  • Blood pressure control with amlodipine is appropriate and should continue

Common Pitfalls to Avoid

  1. Don't delay rheumatology follow-up: Your third appointment via telegram is inadequate given your Grade 2 myositis—you need in-person evaluation with possible treatment escalation

  2. Don't stop medications prematurely: Once started on steroids, you'll need a slow taper over months

  3. Watch for ILD symptoms: Report any new shortness of breath, dry cough, or exercise intolerance immediately (45% risk) 1

  4. Monitor for arthritis: 60% of anti-U1-RNP patients develop joint involvement 1

How Rare Is This for a Male?

Anti-U1-RNP myositis affects males in 33-40% of cases 1, so while less common than in females, it's not exceptionally rare. Your demographic (young Black male) actually fits the typical profile for this condition.

Bottom Line

You have a treatable autoimmune myositis with excellent prognosis when managed appropriately. Your survival rate is essentially 100% with proper treatment 1. The key is aggressive early treatment with corticosteroids, close monitoring for extramuscular manifestations (especially ILD), and early addition of steroid-sparing agents. Your cardiac workup will likely be reassuring, and your current symptoms are manageable with appropriate immunosuppression.

Demand an in-person rheumatology visit sooner than your scheduled telegram appointment—Grade 2 myositis with elevated CK requires prompt treatment initiation, not remote consultation 3.

References

Related Questions

In a 6'5", 320‑lb Black male with mixed connective tissue disease, mild CK elevation (371–527 U/L), speckled ANA with anti‑U1‑RNP positivity, normal EMG, and recent normal cardiac studies, what is the most likely type of inflammatory myopathy, its prognosis, and should I continue physical and occupational therapy?
In a 30‑year‑old Black male, 6′5″, 320 lb, with proximal weakness of the hands, shoulders, hips, thighs and legs, ANA speckled 1:160, anti‑RNP 86 U (normal < 20), CK 527 U/L, mildly elevated ESR and CRP, normal cardiac imaging, normal stress test, normal renal function, and G6PD deficiency, how rare is mixed connective tissue disease (MCTD) with inflammatory myositis, what type of myositis is most likely, and will the upcoming EMG likely demonstrate myopathic changes that necessitate a muscle biopsy?
In a 30-year-old Black male (6'5", 320 lb) with hypertension on amlodipine and GLP‑1 therapy, who has a positive ANA (1:160 speckled), markedly elevated anti‑U1‑RNP, negative anti‑centromere, anti‑Scl‑70, anti‑Sm, anti‑SSA/SSB, and anti‑dsDNA, normal complement C3/C4, mildly elevated CK (371–527 U/L), low‑normal ESR (2–18 mm/h), normal renal and liver function, and an upcoming EMG, what is the most likely diagnosis (inflammatory myositis associated with mixed connective‑tissue disease versus necrotizing autoimmune myopathy), is a muscle biopsy required, and how serious is the condition?
In a 6'5", 318‑lb Black male with mixed connective tissue disease, G6PD deficiency, modestly elevated creatine kinase, positive speckled ANA with elevated anti‑U1 RNP, negative anti‑Jo‑1, normal electromyography, and proximal muscle weakness (tight back, shoulder‑blade discomfort, arm and leg weakness), what specific type of myositis is most likely (necrotizing, dermatomyositis, polymyositis, or inflammatory myopathy) and what is the expected prognosis?
In a 6'5", 320‑lb Black male with mixed connective‑tissue disease, G6PD deficiency, mildly elevated creatinine but normal eGFR, mildly elevated creatine kinase, low‑to‑moderate ESR and CRP, ANA speckled pattern (1:80‑1:160) and anti‑U1‑RNP 4.7 U, presenting with proximal muscle weakness, shoulder‑blade tightness, and a normal EMG, what is the most likely type of inflammatory myopathy (polymyositis, dermatomyositis, necrotizing autoimmune myopathy, etc.), and what is the expected prognosis and recommended management?
What precautions and preparations should a 56-year-old patient with controlled mild persistent asthma who lives in North Carolina take when traveling to Colorado for a mountain hike to prevent asthma exacerbations and altitude illness?
How should impulsivity be managed in a patient taking aripiprazole (Abilify)?
What is the clinical relevance and recommended management of cervical calcification in middle‑aged and older adults?
Should a 70-year-old patient with diabetes receive the 20-valent pneumococcal conjugate vaccine (PCV20) or the 23-valent pneumococcal polysaccharide vaccine (PPSV23) given that his last pneumococcal vaccine was PPSV23 six years ago?
Is Depakote (valproic acid) appropriate for treating anger or aggressive outbursts in an adult, and what are the recommended dosing, monitoring, and safety considerations?
What is the best mood stabilizer for anger management in a patient with normal renal and thyroid function and no lithium intolerance?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.